These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 22276833)
21. Methotrexate and psoriasis: consensus conference. Kalb RE; Strober B; Weinstein G; Lebwohl M J Am Acad Dermatol; 2011 Jun; 64(6):1179. PubMed ID: 21571176 [No Abstract] [Full Text] [Related]
22. Systemic therapy of psoriasis using methotrexate. Smith KC Skin Therapy Lett; 2000; 6(3):1-2; 5. PubMed ID: 11176041 [TBL] [Abstract][Full Text] [Related]
23. Briakinumab for the treatment of plaque psoriasis. Traczewski P; Rudnicka L BioDrugs; 2012 Feb; 26(1):9-20. PubMed ID: 22077474 [TBL] [Abstract][Full Text] [Related]
24. Disseminated cryptococcal infection in a patient with severe psoriasis treated with efalizumab, methotrexate and ciclosporin. Tuxen AJ; Yong MK; Street AC; Dolianitis C Br J Dermatol; 2007 Nov; 157(5):1067-8. PubMed ID: 17854358 [No Abstract] [Full Text] [Related]
25. Low dose acitretin versus methotrexate in the treatment of palmoplantar psoriasis: a case series. Gisondi P; Mattiucci A; Tonin B; Girolomoni G J Eur Acad Dermatol Venereol; 2019 Jun; 33(6):e246-e247. PubMed ID: 30801786 [No Abstract] [Full Text] [Related]
26. Methotrexate in the treatment of psoriasis. Bright RD Cutis; 1999 Nov; 64(5):332-4. PubMed ID: 10582158 [TBL] [Abstract][Full Text] [Related]
27. [Methotrexate therapy in psoriasis]. Bournerias I Rev Prat; 2004 Jan; 54(1):52-5. PubMed ID: 15049601 [TBL] [Abstract][Full Text] [Related]
28. [Question of the month. Is there any risk of prescribing methotrexate in psoriasis, the use of which is not legally allowed in France?]. Ann Dermatol Venereol; 1996; 123(12):861-4. PubMed ID: 9636783 [No Abstract] [Full Text] [Related]
30. Complete reversion of anti-infliximab immunization by methotrexate combination in a patient with psoriasis. Vincent T; Best M; Plawecki M; Girard C J Dermatol; 2015 Oct; 42(10):1030-1. PubMed ID: 26119228 [No Abstract] [Full Text] [Related]
32. [Eventration and methotrexate in psoriasis]. Schmutz JL; Barbaud A; Trechot P Ann Dermatol Venereol; 2010 Oct; 137(10):672. PubMed ID: 20932456 [No Abstract] [Full Text] [Related]
33. Combining biologics with methotrexate in psoriasis: a systematic review. van Bezooijen JS; Prens EP; Pradeepti MS; Atiqi R; Schreurs MWJ; Koch BCP; van Gelder T; van Doorn MBA Br J Dermatol; 2015 Jun; 172(6):1676-1680. PubMed ID: 25470815 [No Abstract] [Full Text] [Related]
34. Topical psoriasis therapies and unmet patient needs: the importance of optimizing methotrexate. Greenberg R Cutis; 2016 Jan; 97(1):55-6. PubMed ID: 26919356 [No Abstract] [Full Text] [Related]
35. Intermittent, short term use of methotrexate for exacerbations of psoriasis. Clark AR; Feldman SR Int J Dermatol; 1997 Dec; 36(12):954-5. PubMed ID: 9466209 [No Abstract] [Full Text] [Related]
36. [Patient education. Information letter on treatment of psoriasis with methotrexate]. Groupe de recherche sur psoriasis de Société française de dermatologie, mai 2011 Ann Dermatol Venereol; 2011 Dec; 138(12):861-2. PubMed ID: 22137631 [No Abstract] [Full Text] [Related]
38. Methotrexate and other chemotherapeutic agents used to treat psoriasis. Jeffes EW; Weinstein GD Dermatol Clin; 1995 Oct; 13(4):875-90. PubMed ID: 8785891 [TBL] [Abstract][Full Text] [Related]
39. [Biologics in the treatment of psoriasis]. Dissemond J; Grabbe S MMW Fortschr Med; 2006 Sep; 148(38):42-4. PubMed ID: 17036963 [TBL] [Abstract][Full Text] [Related]
40. [What is the impact of the new clinical trial data? What are the lessons for patient management?]. Passeron T; Boulinguez S Ann Dermatol Venereol; 2010 May; 137(5 Suppl 1):11-5. PubMed ID: 20510174 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]